Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company, will be added to the Russell 3000®, Russell 2000®, and Russell ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE